Skip to content

All Courses

FDA Second Annual Animal Drug User Fee Educational Conference – July 2025
FDA Second Annual Animal Drug User Fee Educational Conference - July 2025

FDA Second Annual Animal Drug User Fee Educational Conference – July 2025

FDA Cell and Gene Therapy Roundtable (June 2025)
FDA Cell and Gene Therapy Roundtable (June 2025)

FDA Cell and Gene Therapy Roundtable (June 2025)

FDA Generic Drug Science and Research Initiatives Public Workshop 2025
FDA Generic Drug Science and Research Initiatives Public Workshop 2025

FDA Generic Drug Science and Research Initiatives Public Workshop 2025

OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2025 User Fees and Registration
FDA CDER Understanding OMUFA FY 2025 User Fees and Registration Webinar - May 2025

OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2025 User Fees and Registration

FDA CDER Overview: Certificates of Confidentiality
FDA CDER Overview: Certificates of Confidentiality

FDA CDER Overview: Certificates of Confidentiality

FDA Pre-Existing Tobacco Product (PTP) Determination Program
FDA Pre-Existing Tobacco Product (PTP) Determination Program

FDA Pre-Existing Tobacco Product (PTP) Determination Program

FDA CDER Bioresearch Monitoring: Electronic Submission Requirements for New Drug and Biologic Licensing Applications
CDER Bioresearch Monitoring Webinar

FDA CDER Bioresearch Monitoring: Electronic Submission Requirements for New Drug and Biologic Licensing Applications

FDA CFSAN Updated “Healthy” Nutrient Content Claim: Final Rule
FDA CFSAN Healthy Nutrient Content Claim Webinar

FDA CFSAN Updated “Healthy” Nutrient Content Claim: Final Rule

FDA Generic Drugs Forum 2025
FDA Generic Drugs Forum 2025

FDA Generic Drugs Forum 2025

Model Master Files: Advancing Modeling and Simulation in Generic Drug Development and Regulatory Submissions
Model Master Files Advancing Modeling and Simulation in Generic Drug Development and Regulatory Submissions

Model Master Files: Advancing Modeling and Simulation in Generic Drug Development and Regulatory Submissions

1 2 3 4 5
Share: